000 01380 a2200349 4500
005 20250515235409.0
264 0 _c20110131
008 201101s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00551-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuvens, Glenn
245 0 0 _aAntimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cNov 2010
300 _a4907-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdhesins, Bacterial
_xgenetics
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aDrug Resistance, Multiple, Bacterial
_xgenetics
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aEscherichia coli Proteins
_xgenetics
650 0 4 _aHumans
650 0 4 _aPlasmids
_xgenetics
650 0 4 _aShiga Toxins
_xmetabolism
650 0 4 _abeta-Lactamases
_xgenetics
700 1 _aBogaerts, Pierre
700 1 _aGlupczynski, Youri
700 1 _aLauwers, Sabine
700 1 _aPiérard, Denis
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 54
_gno. 11
_gp. 4907-9
856 4 0 _uhttps://doi.org/10.1128/AAC.00551-10
_zAvailable from publisher's website
999 _c20068380
_d20068380